INTRODUCTION
The peri-implantation period represents a critical point in pregnancy when a well-organized dialogue between the endometrium and conceptus (embryo and its extraembryonic membranes) must be established to ensure a suitable environment for implantation and conceptus development [1, 2] . During early pregnancy, the developing preimplantation conceptus depends on a sufficient supply of histotroph for survival, growth, and development. This coordinated interaction at the maternal-conceptus interface is especially important in pigs that have a noninvasive central-type implantation in preparation for a true epitheliochorial placentation that involves a prolonged preattachment phase [3] .
Vascular endothelial growth factor (VEGF; also referred to as VEGF-A), a homodimeric heparin-binding glycoprotein, is one of the potent regulators participating in maternal-conceptus interactions. In humans, alternatively spliced variants, consisting of VEGF 121, 145, 165, 183, 189, and 206, were discovered [4] [5] [6] . Among these isoforms, VEGF 165 appears to be the primary isoform most frequently expressed [7, 8] . Charnock-Jones et al. [9] revealed that VEGF 164 was the most abundant isoform in the pregnant uterus of pigs and that it was localized at the maternal-fetal interface. The biological effects of VEGF are mediated via binding to high-affinity tyrosine kinase receptors: VEGFR-1 (c-fms-like tyrosine kinase ) and VEGFR-2 (fetal liver kinase-1/kinase domain-containing receptor [Flk-1/KDR]) [10] . After binding to VEGFR-1 or VEGFR-2, VEGF induces their dimerization and autophosphorylation of receptor kinase, which activates intracellular signaling cascades. Although VEGF affinity is highest for VEGFR-1, VEGFR-2 has more potent angiogenetic activity in response to VEGF [8, 11] .
VEGF plays a critical role in formation of new blood vessels and regulation of the permeability in a variety of tissues. VEGF in reproductive organs has been described in various species as a regulatory factor participating in mammalian reproduction [7, 10, 12, 13] . VEGF expression seems to correlate with implantation processes by stimulating endothelial cell proliferation and vascular permeability [13] [14] [15] . VEGF-induced vascular remodeling is crucial for an optimal uterine environment at the implantation site in species with an invasive type of implantation. The VEGF-receptor system also plays an important role in early embryonic development. Gene knockout studies have shown that inactivation of a single allele for VEGF in mice results in embryonic abnormalities and early embryonic death [16, 17] . Mice carrying disrupted VEGFR-1 and VEGFR-2 genes also experience developmental defects and early embryonic lethality [18] . Additionally, the addition of recombinant VEGF to an in vitro culture medium stimulated outgrowth and cell numbers of porcine blastocysts [19] .
During estrous cycle and pregnancy in pigs, the uterine VEGF-receptor system is expressed in glandular and luminal epithelia, arteries, arterioles, and myometrial smooth muscle cells [20, 21] . Maternal blood flow increases on Days 12 and 13 of pregnancy, when there are also significant increases in expression of VEGF, VEGFR-1, and VEGFR-2 mRNAs in the porcine endometrium [21] [22] [23] [24] [25] . These increases coincide temporally with the dramatic elongation of spherical and tubular blastocysts to the filamentous stage and secretion of estrogens by the trophoblast. Also, early embryonic transcripts for VEGF are detectable from the oocyte to the blastocyst stages, and both VEGF receptors are expressed from the onecell to the blastocyst stage [19] . The fact that expression of the VEGF-receptor system is detectable throughout the periimplantation period in trophoblast cells, which are not endothelial cells and in which no angiogenesis occurs, raises the possibility that VEGF has nonangiogenetic roles in the trophectoderm. But most studies have focused primarily on angiogenetic effects of the endometrial VEGF-receptor system during the peri-implantation period of pregnancy.
In this study, we ask whether VEGF, originally identified as an angiogenetic factor, also plays a novel role in periimplantation events by modulating development and function of trophectoderm cells. This study tested the hypothesis that during early pregnancy in pigs, the VEGF-receptor system of both the endometrium and the conceptus is critical for growth and development of porcine trophectoderm (pTr) cells during the peri-implantation period of pregnancy. Therefore, we determined 1) stimulatory effects of VEGF on PI3K-AKT1 and MAPK cascades in pTr cells and 2) functional effects of VEGF on proliferation and migration of pTr cells.
MATERIALS AND METHODS

Experimental Animals and Animal Care
Sexually mature gilts of similar age, weight, and genetic background were observed daily for estrus (Day 0) and exhibited at least two estrous cycles of normal duration (18-21 days) before being used in this study. All experimental and surgical procedures were in compliance with the Guide for Care and Use of Agricultural Animals in Teaching and Research and approved by the Institutional Animal Care and Use Committee of Texas A&M University.
Experimental Design and Tissue Collection
Gilts were assigned randomly to either cyclic or pregnant status. Those in the pregnant group were bred when detected in estrus and 12 and 24 h later. Gilts were ovariohysterectomized on either Day 9, 12, or 15 of the estrous cycle or on Day 9, 10, 12, 13, 14, 15, or 20 of pregnancy (n ¼ 3-4 pigs per day per status). For confirmation of pregnancy prior to implantation, the lumen of each uterine horn was flushed with 20 ml of physiological saline and examined for the presence of morphologically normal conceptuses. Uteri from cyclic and pregnant gilts were processed to obtain several sections (;0.5 cm) from the entire uterine wall in the middle of each uterine horn, the tissue was fixed in fresh 4% paraformaldehyde in PBS (pH 7.2), and the tissue was embedded in Paraplast-Plus (Oxford Laboratory).
Cell Culture
The spontaneously immortalized mononuclear pTr cell line from Day 12 pig conceptuses were cultured and used in the present in vitro studies as described previously [26] . For experiments, monolayer cultures of pTr cells were grown in culture medium to 80% confluence in 100-mm tissue culture dishes. Cells were serum starved for 24 h and then treated with recombinant human VEGF (R&D Systems, Inc.) for 0, 5, 15, 30, 60, or 120 min. Based on preliminary dose-response experiments, 20 ng/ml VEGF was selected for use in all experiments in the present study. This design was replicated in three independent experiments.
RNA Isolation
Total cellular RNA was isolated from endometrium of cyclic and pregnant gilts using Trizol reagent (Invitrogen) and purified using an RNeasy Mini Kit (Qiagen) according to the manufacturer's recommendations. The quantity and quality of total RNA was determined by spectrometry and denaturing agarose gel electrophoresis, respectively.
Cloning of Partial cDNA for Porcine VEGF, VEGFR-1, and VEGFR-2
Complementary DNA was synthesized using AccuPower RT PreMix (Bioneer Inc.). Partial cDNAs for porcine VEGF, VEGFR-1, and VEGFR-2 mRNAs were amplified using specific primers based on data for porcine VEGF (GenBank accession no. NM_214084.1: forward, 5 0 -CGA AGT GGT GAA GTT CAT GG-3 0 ; reverse, 5 0 -TCA CAT CTG CAA GTA CGT TCG-3 0 ), VEGFR-1 mRNA (GenBank accession no. AY566244.1; forward, 5 0 -ACA AAG ACC CCA AAG AAA GG-3 0 ; reverse, 5 0 -GGG AGT GGA GTA CGT GAA GC-3 0 ), and VEGFR-2 mRNA (GenBank accession no. AJ245446.1; forward, 5 0 -CAG AGT GGC TCT GAG GAA CG-3 0 ; reverse, 5 0 -CTG GAT ACC TCG CAC AAA GG-3 0 ). The partial cDNAs for VEGF, VEGFR-1, and VEGFR-2 were gel extracted and cloned into the TOPO TA cloning vector (Invitrogen).
Quantitative PCR Analysis
Specific primers for porcine VEGF 164 (forward: 5 0 -CTA CCT CCA CCA TGC CAA GT-3 0 ; reverse: 5 0 -ACA CAG GAC GGC TTG AAG AT-3 0 ), VEGFR-1 (forward: 5 0 -GAA AGG CCA AGA TTT GTG GA-3 0 ; reverse: 5 0 -GGG AGT GGA GTA CGT GAA GC-3 0 ), and VEGFR-2 (forward: 5 0 -TGA TCG GAA ATG ACA CTG GA-3 0 ; reverse: 5 0 -TTG AAA TGG TCC CCA GAC AT-3 0 ) were designed from sequences in the GenBank database using Primer 3 (ver. 4.0.0). All primers were synthesized by Bioneer. Gene expression levels were measured using SYBR Green (Sigma) and a StepOnePlus Real-Time PCR System (Applied Biosystems). The PCR conditions were 958C for 3 min, followed by 40 cycles at 958C for 20 sec, 648C for 40 sec, and 728C for 1 min using a melting curve program (increasing the temperature from 558C to 958C at 0.58C per 10 sec) and continuous fluorescence measurements. Sequence-specific products were identified by generating a melting curve in which the C T value represented the cycle number at which a fluorescent signal was significantly greater than background, and relative gene expression was quantified using the 2 -DDCT method. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as the endogenous control to standardize the amount of RNA in each reaction.
In Situ Hybridization Analysis
After verification of the sequences, the plasmids containing gene sequences were amplified with T7-and SP6-specific primers (T7:5 0 -TGT AAT ACG ACT CAC TAT AGG G-3 0 ; SP6:5 0 -CTA TTT AGG TGA CAC TAT AGA AT-3 0 ), and then digoxigenin (DIG)-labeled RNA probes were transcribed using a DIG RNA labeling kit (Roche Applied Science). The tissue sections were deparaffinized, rehydrated, and treated with 1% Triton X-100 in PBS for 20 min and washed two times in DEPC-treated PBS. After postfixation in 4% paraformaldehyde, sections were incubated in a prehybridization mixture containing 50% formamide and 43 standard saline citrate for at least 10 min at room temperature. After hybridization and blocking steps, the sections were incubated overnight with sheep anti-DIG antibody conjugated to alkaline phosphatase (Roche). The signal was visualized by exposure to a solution containing 0.4 mM 5-bromo-4-chloro-3-indolyl phosphate, 0.4 mM nitroblue tetrazolium, and 2 mM levamisole (Sigma).
Western Blot Analyses
Concentrations of protein in whole-cell extracts were determined using the Bradford protein assay (Bio-Rad) with bovine serum albumin as the standard. Proteins were denatured, separated using SDS-PAGE, and transferred to nitrocellulose. Blots were developed using enhanced chemiluminescence detection (SuperSignal West Pico; Pierce) and quantified by measuring the JEONG ET AL.
intensity of light emitted from correctly sized bands under ultraviolet light using a ChemiDoc EQ system and Quantity One software (Bio-Rad). Immunoreactive proteins were detected using rabbit anti-mouse polyclonal antibodies against p-AKT1 and AKT1 at a 1:1000 dilution and 10% SDS-PAGE gel, rabbit anti-human polyclonal antibodies against p-RPS6 and rabbit anti-human monoclonal antibodies against RPS6 at a 1:1000 dilution and 10% SDS-PAGE gel, rabbit anti-human polyclonal antibodies against p-p70RSK and p70 RSK at a 1:1000 dilution and 10% SDS-PAGE gel, rabbit anti-mouse polyclonal antibodies against p-4EBP1 and rabbit anti-human polyclonal antibodies against 4EBP1 at a 1:1000 dilution and 12% SDS-PAGE gel, and rabbit anti-human polyclonal p-ERK1/2 MAPK and rabbit anti-human monoclonal ERK1/2 MAPK IgG, each at a 1:1000 dilution, and 12% SDS-PAGE gel. As a loading control, mouse anti-a-tubulin (TUBA) was used to normalize results from detection of proteins by Western blotting. All antibodies were from Cell Signaling Technology. Multiple exposures of each Western blot were performed to ensure linearity of chemiluminescent signals.
Proliferation Assay
Proliferation assays were conducted using Cell Proliferation ELISA, BrdU kit (Roche), according to the manufacturer's recommendations. Briefly, pTr cells were seeded in a 96-well microplate (tissue culture grade, flat bottom), and then incubated for 24 h in serum-free DMEM/F-12. Cells were then treated with recombinant VEGF protein and various treatments in a final volume of 100 ll/well. After 24 h of incubation, 10 lM BrdU were added to the cell culture, and the cells were reincubated for an additional 24 h at 378C. After labeling of cells with BrdU, the fixed cells were incubated with anti-BrdU-POD working solution for 90 min. The anti-BrdU-POD binds to the BrdU incorporated in newly synthesized cellular DNA, and these immune complexes were detected by the reaction to TMB substrate solution. The absorbance values of the reaction product were quantified by measuring the absorbance at 370 nm using an ELISA reader (Bio-Rad).
Migration Assay
The pTr cells (50 000 cells per 100 ll serum and insulin-free DMEM/F12) were seeded on 8-lm-pore transwell inserts (Corning Costar no. 3422; Corning, Inc.) and treatments added to each well (n ¼ 3 wells per treatment). After 12 h, cells on the upper side of the inserts were removed with a cotton swab. For evaluation of cells that migrated onto the lower surface, inserts were fixed in 50% ethanol for 5 min. The transwell membranes were then removed, placed on a glass slide with the side containing cells facing up, overlaid with prolong antifade mounting reagent with 4 0 ,6-diamidino-2-phenylindole, and overlaid with a coverslip (Invitrogen-Molecular Probes). Migrated cells were counted systematically in five nonoverlapping locations that covered approximately 70% of the insert membrane growth area using a Zeiss Axioplan 2 fluorescence microscope with Axiocam HR digital camera and Axiovision 4.3 software (Carl Zeiss Microimaging). The entire experiment was repeated at least three times.
Reagents
Rabbit anti-human polyclonal antibodies against p-ERK1/2 MAPK (catalog no. 9101), p-RPS6 (catalog no. 2211), p-p70RSK (catalog no. 9204), p70RSK (catalog no. 9202), and 4EBP1 (catalog no. 9452); rabbit anti-human monoclonal antibody against RPS6 (catalog no. 2217) and ERK1/2 MAPK (catalog no. 4695); and rabbit anti-mouse polyclonal antibodies against p-AKT1 (catalog v 9271), AKT1 (catalog no. 9272), and p-4EBP1 (catalog no. 9451) were purchased from Cell Signaling Technology, Inc. Inhibitors for PI3K (LY294002, catalog no. 9901), MEK1/2 (U0126, catalog no. 9903), P38 MAPK (SB203580, catalog no. 5633), and mTOR (Rapamycin, catalog no. 5633) were also obtained from Cell Signaling Technology.
Statistical Analyses
All quantitative data were subjected to least-squares analysis of variance using the General Linear Model procedures of the Statistical Analysis System (SAS Institute Inc.). Western blot data were corrected for differences in sample loading using the TUBA data as a covariate. All tests of significance were performed using the appropriate error terms according to the expectation of the mean squares for error. A P-value less than or equal to 0.05 was considered significant. Data are presented as least-square means with SEM.
RESULTS
Changes in Expression of Endometrial VEGF, VEGFR-1, and VEGFR-2 mRNAs and Their Localization in Porcine Endometria During the Estrous Cycle and Pregnancy
Uterine VEGF mRNA levels in cyclic and pregnant pigs were determined by quantitative RT-PCR analysis (Fig. 1A) . Steady-state levels of VEGF mRNA in the uterus were not affected by day of the estrous cycle (day, P . 0.05), but expression of VEGF mRNA on Day 12 and Day 15 of pregnancy was higher (P , 0.001 and P , 0.01) than on Day 12 and Day 15 of the estrous cycle. In situ hybridization analysis was used to detect cell-specific localization of VEGF mRNAs in pig endometria during the estrous cycle and pregnancy (Fig. 1B) . In cyclic gilts, VEGF mRNA was localized primarily to uterine luminal (LE) and glandular (GE) epithelial cells, and there was strong expression of endometrial VEGF mRNA in uterine GE on Day 9 of the estrous cycle. Similarly, endometrial VEGF mRNA was localized primarily to uterine LE, GE, and stratum compactum stroma during pregnancy, and expression of VEGF mRNA in LE and stratum compactum stroma was abundant between Days 9 and 13 of pregnancy. As shown in Figure 2A , no significant differences were found in VEGFR-1 and VEGFR-2 transcripts due to day of the estrous cycle (day, P . 0.05), but VEGFR-1 mRNA levels gradually increased 7.6-fold (P , 0.001) from Day 9 of pregnancy to Day 14 of pregnancy and, then declined to levels similar to Day 15 of the estrous cycle on Day 20 of pregnancy ( Fig. 2A) . VEGFR-2 mRNA also increased 5.6-fold (P , 0.001) from Day 9 to Day 14 of pregnancy and then decreased slightly on Day 20 of pregnancy but remained higher than those on the same days of the estrous cycle (Fig. 2B) . In situ hybridization analysis was used to detect cell-specific localization of VEGFR-1 and VEGFR-2 mRNAs in pig endometria during the estrous cycle and pregnancy (Fig. 2, C and D) . In cyclic gilts, there was low expression of VEGR-1 mRNA in uterine LE and GE except for LE expression of VEGFR-1 mRNA on Day 12 of the estrous cycle. In pregnant gilts, VEGFR-1 mRNA expression was localized to uterine LE and scattered cells in the stratum compactum stroma between Days 9 and 13 of pregnancy. VEGFR-1 mRNA was also detected in conceptus trophectoderm but was barely detectable in uterine LE, GE, and stromal cells on Day 20 of pregnancy. VEGFR-2 mRNA expression was localized to uterine LE, GE, and stratum compactum stroma between Day 9 and Day 12 of the estrous cycle. In pregnant gilts, strong expression of VEGFR-2 mRNA was detected in uterine LE, GE, endothelial blood vessels, and scattered cells in stratum compactum stroma. On Days 13 and 14 of pregnancy, VEGFR-2 mRNA was also detectable in conceptus trophectoderm. Taken together, these results demonstrated that VEGF and VEGF receptors are expressed abundantly in uterine LE, GE, and stratum compactum stroma as well as conceptus trophectoderm during the peri-implantation period of pregnancy in pigs.
Effect of VEGF on PI3K-AKT1 and MAPK Cell Signaling and on Proliferation and Migration of pTr Cells VEGF stimulated phosphorylation of AKT1 and ERK1/2 in pTr cells in a dose-dependent manner (Fig. 3A) . Under the same specific culture conditions, we measured dose-dependent effects of VEGF (0, 0.1, 1, 20, and 100 ng/ml) on proliferation and migration of pTr cells (Fig. 3, B and C) . At 20 ng/ml or 100 ng/ml, VEGF increased pTr cell proliferation by approximately 148% and 149% (P , 0.05), respectively.
VEGF-INDUCED pTr CELL SIGNALING PATHWAYS
Similarly, VEGF stimulated migration of pTr cells approximately 219% and 225% (P , 0.01) at 20 ng/ml and 100 ng/ml, respectively. Based on those results, VEGF was used at 20 ng/ ml in experiments to determine its effects on cell signaling pathways. VEGF stimulated a rapid 2.8-fold and 4.1-fold (P , 0.01) increase in the abundance of phosphorylated AKT1 (p-AKT1) and phosphorylated ERK1/2 MAPK (p-ERK1/2 MAPK), respectively, within 5 min after treatment, and those levels of phosphorylation were maintained to 15 min (Fig. 3, D and E). VEGF also increased the abundance of phosphorylated p70RSK (p-p70RSK), phosphorylated RPS6 (p-RPS6), and phosphorylated 4EBP1 (p-4EBP1) in a time-dependent manner, reaching 5.4-, 8.4-, and 3.3-fold (P , 0.001), respectively, at 30 min posttreatment and then gradually decreased through 120 min but remained higher than basal levels (Fig. 3, F-H) .
FIG. 1.
Relative quantification and localization of VEGF mRNAs in endometria of gilts during the estrous cycle and pregnancy by quantitative RT-PCR and in situ hybridization analyses. A) Expression of VEGF mRNAs in endometria from cyclic and pregnant gilts. VEGF mRNA levels were not affected by day of the estrous cycle, but there were effects of day of pregnancy on expression of VEGF mRNA (day, P , 0.001 or 0.01). The asterisks denote statistically significant differences (***P , 0.001 and **P , 0.01). B) In situ hybridization analyses of VEGF mRNAs in the porcine uterus. Cross sections of the uterus from Day 12 of pregnancy were hybridized with DIG-labeled sense porcine VEGF cRNA probes as a negative control. cy, estrous cycle; px, pregnancy; LE, luminal epithelium; GE, glandular epithelium. Bar ¼ 100 lm. Images were captured at 310 and 340 objective magnifications.
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Activation of PI3K-AKT1 and ERK1/2 MAPK Signaling Pathways in pTr in Response to VEGF
Effects of VEGF on PI3K-AKT1 and MAPK cell signal transduction in pTr cells were investigated using pharmacological inhibitors of PI3K (20 lM LY294002) and ERK1/2 MAPK activity (20 lM U0126). Serum-starved pTr cells were incubated with either LY294002 (20 lM) or U0126 (20 lM) for 1 h prior to treatment with VEGF (20 ng/ml). VEGFinduced phosphorylation of AKT1 was completely inhibited by the PI3K inhibitor (P , 0.001), while U0126 did not affect the abundance of VEGF-induced p-AKT1 protein (P . 0.05; Fig.  4A ). VEGF-induced increases in phospho-ERK1/2 were blocked by both U0126 and LY294002 (P , 0.001; Fig.  4B ). These results suggest that VEGF induces activation of both PI3K-AKT1 and ERK1/2 MAPK cell signaling pathways in pTr cells and that ERK1/2 MAPK is a downstream target of PI3K in the regulation of VEGF-induced cell signaling.
VEGF-Induced Proliferation and Migration of pTr Cells Through Various Signal Transduction Cascades
To confirm whether PI3K-AKT1 and ERK1/2 MAPK signal transduction pathways are involved in effects of VEGF on proliferation of pTr cells, cell proliferation and migration assays were conducted in the presence or absence of VEGF (20 ng/ml), U0126, or LY294002. VEGF increased pTr cell numbers by approximately 134% (P , 0.01; Fig. 5A ).
However, pretreatment with U0126 or LY294002 plus VEGF reduced pTr cell numbers (P , 0.001) as compared to VEGF treatment alone. To examine involvement of other intracellular messengers, we used pharmacological inhibitors of P38 MAPK (SB203580) and FRAP/mTOR activity (rapamycin). Interestingly, both of those inhibitors also blocked effects of VEGF on proliferation of pTr cells (P , 0.001). Using transwell plates, we investigated functional effects of VEGF on pTr cell migration. Treatment of pTr cells with VEGF alone stimulated cell migration by approximately 201% (P , 0.001 or P , 0.01), but SB203580, U0126, rapamycin, and LY294002 inhibited the stimulatory effects of VEGF on pTr cell migration by 126%, 81%, 146%, and 130%, respectively (P , 0.01; Fig.  5B ). In the absence of VEGF, treatment of pTr cells with those inhibitors only had no effect on pTr cell migration. These results suggest that activation of PI3K-AKT1-p70RSK and ERK1/2 or P38 MAPK signaling pathways play an important role in stimulation of pTr cell proliferation and migration in response to VEGF from endometrial and/or conceptus tissues.
DISCUSSION
The results of this study revealed stimulatory effects of endometrial-and/or conceptus-derived VEGF on proliferation and migration of pTr cells via the PI3K-AKT1-mTOR and MAPK signaling pathways (Fig. 6) . The results provide evidence for novel roles of VEGF in regulating development of pTr during the peri-implantation period of pregnancy and 
VEGF-INDUCED pTr CELL SIGNALING PATHWAYS
indicate regulatory cell signaling mechanisms. Successful implantation requires a synchronized conceptus-maternal dialogue via locally produced mediators, such as growth factor and cytokines. Deficiencies in those factors can result in implantation failure, defective placentation, and developmental abnormalities. Previous studies with the uterine gland knockout sheep model emphasize the importance of secretions from uterine glands for implantation and placentation [27] [28] [29] . VEGF in the uterine cavity is likely to be an important regulator of implantation [30] . In pigs, early pregnancy is characterized by rapid morphological changes and development of conceptus and endometrium [31] . Morphological changes of the uterus include VEGF-mediated development and remodeling of endometrial vasculature and increased uterine vascular permeability, which is necessary for successful growth of the conceptus and establishment of pregnancy [32] [33] [34] [35] . VEGF from the conceptus could be important in implantation, possibly by inducing implantation site-specific angiogenesis [36] .
In addition to the known angiogenetic effects of VEGF, circumstantial evidence suggests novel mechanisms by which VEGF regulate early embryo during peri-implantation. Recently, Hannan et al. [37] demonstrated that concentrations of VEGF in uterine fluids were less in infertile women as compared with fertile women and that addition of recombinant VEGF to cell culture conditions stimulated outgrowth of mouse   FIG. 3 . VEGF influences the abundance of phosphorylated AKT1, ERK1/2, P70RSK, RPS6, and 4EBP1 proteins and stimulates migration and proliferation of pTr cells. A) Western blot analyses revealed dose-dependent effects of VEGF to increase the abundance of p-AKT1 and p-ERK1/2 proteins in pTr cells in vitro. Tubulin-alpha (TUBA) was the total protein control. B) The effect of VEGF (0, 0.1, 1, 20, and 100 ng/ml) on pTr cell proliferation. C) The effect of VEGF (0, 0.1, 1, 20, and 100 ng/ml) on pTr cell migration. D) p-AKT1 and AKT1 were detected between 0 and 120 min after treatment of pTr cells with VEGF. E) p-ERK1/2 and ERK1/2 were detected between 0 and 120 min in pTr cells treated with VEGF. F) p-p70RSK and p70RSK were detected between 0 and 120 min after treatment of pTr cells with VEGF. G) p-RPS6 and RPS6 were detected between 0 and 120 min after treatment of pTr cells with VEGF. H) p-4EBP1 and 4EBP1 were detected between 0 and 120 min after treatment of pTr cells with VEGF. Blots were imaged to calculate the normalized values presented in the graph by measurements of abundance of phosphorylated proteins relative to total protein. The asterisks denote significant differences (***P , 0.001, **P , 0.01, and *P , 0.05).
blastocyst and adhesion of human endometrial epithelial cells. Although in vitro studies with human extravillous trophoblast have provided contrary results, VEGF may influence proliferation or migration of extravillous trophoblast cells [38] [39] [40] [41] [42] . Additionally, VEGF supplementation in the in vitro culture medium is known to improve the rate of blastocyst formation and to increase blastocyst cell number [19, 43] . But knowledge on the role of the VEGF-receptor system and, especially its regulatory mechanisms at the maternal-conceptus interface, is very limited in pigs. During the peri-implantation period, porcine embryonic transcripts for the VEGF-receptor system have been detected from the one-cell to the blastocyst stage [19] . Since there is no angiogenesis occurring in the periimplantation embryos, these findings suggest that VEGF may induce novel functions other than angiogenetic responses in blastocysts and conceptuses during the peri-implantation period.
VEGF is known to exist in the uterus of various mammals, such as human, mouse, rat, ewe, rabbit, and pig [7, 12, 20, 44, 45] , and VEGF is secreted by a wide range of tissues and cells, including glandular epithelia, luminal epithelia, stroma, glial, tumor, and smooth muscle cells, as well as macrophages, keratinocytes, and cells of ovarian cysts [46] . In the present study, we demonstrated temporal-and cell-specific expression of the VEGF-receptor system in the porcine endometrium on different stages of the estrous cycle and early pregnancy. Transcripts for VEGF and its two receptors were detectable in LE, GE, scattered cells within the stroma, and vessel walls of cyclic or pregnant endometrium as reported by Kaczmarek et al. [25] . Our results also indicated up-regulation of endometrial transcripts for the VEGF-receptor system during the periimplantation period, when proliferation and migration of trophectoderm cells allow for rapid elongation of the conceptus, indicating that the VEGF-receptor system acts in an autocrine and paracrine manner to stimulate growth and development of the conceptus. Our results support previous findings of increased endometrial vessel permeability and blood flow between Days 12 and 13 of pregnancy [34] . Spatial and temporal expression of the VEGF-receptor system is regulated by ovarian steroids, such as progesterone and estrogen, both in vitro and in vivo [12, 44, [47] [48] [49] . For example, previous research with sheep found that estrogen stimulates production of VEGF by vascular smooth muscle cells [45] . In addition, interleukin (IL)-1a, IL-6, and several growth factors, including insulin-like growth factor, fibroblast growth factor, transforming growth factors, fibroblast growth factor 7, and platelet-derived growth factor, induce VEGF expression [50] .
Although the importance of the VEGF system in implantation events has been documented, the regulatory mechanisms of VEGF action in the porcine conceptus during the periimplantation period are not well understood. The PI3K-AKT1 cell signaling pathway has emerged as a central component that controls cell growth and proliferation through transmitting signals arising from various mitogens and nutrients [51] [52] [53] . In the present study, VEGF stimulation induced rapid activation of AKT1 in pTr cells. The 70-kDa ribosomal S6 kinase (p70RSK), one of the common downstream targets of PI3K-AKT1 and mTOR pathways, was also activated by VEGF stimulation in pTr cells. Various mitogens and growth factors activate p70RSK protein, and then the activated p70RSK transduces the signal via phosphorylation of downstream targets [54] . The primary downstream target of p70RSK is the 40S ribosomal protein S6 (RPS6), which is a major regulatory component of the protein synthetic machinery in mammalian cells [55, 56] . The increase in translation of specific transcripts is a typical response to mitogen stimulation. In this study, VEGF also induced increases in phosphorylation of RPS6 proteins in pTr cells. We also found that VEGF activates phosphorylation of eIF4-binding proteins (4EBP1) by mTOR. Activation of the mTOR leads to phosphorylation of 4EBP1, resulting in its dissociation from eIF4E, which VEGF-INDUCED pTr CELL SIGNALING PATHWAYS stimulates mRNA translation. Furthermore, as shown in Figure  5 , pharmacological inhibitors of both PI3K (LY294002) and mTOR (rapamycin) abolished VEGF-induced proliferation and migration of pTr cells, indicating a central role of these cell signaling pathways in these processes. Taken together, we propose that VEGF induces activation of the PI3K-AKT1-mTOR cell signaling pathway, ultimately stimulating protein synthesis required for proliferation and migration of pTr cells.
Results of the present study further demonstrated that the MAPK cascade is involved in VEGF-induced proliferation and migration of pTr cells. The MAPK pathway has been implicated in regulation of various cellular processes in response to diverse stimuli, including growth factors in a number of model systems [57, 58] . Among subfamilies of MAPKs, ERK1/2 and P38 MAPK pathways have been widely studied and established as major cascades in differentiation processes, including embryonic and placental development [59, 60] . In the present study, VEGF induced a rapid increase in phosphorylation of ERK1/2 proteins in pTr cells. Also, as shown in Figure 5 , pharmacological inhibitors of both ERK1/2 MAPK (U0126) and P38 MAPK activity (SB203580) abolished VEGF-induced proliferation and migration of pTr cells. Taken together, these results indicate that VEGF influences porcine conceptus development by simultaneously, stimulating both the PI3K-AKT1 and the MAPK cell signaling cascades during early pregnancy.
Given the involvement of both PI3K-AKT1 and ERK1/2 MAPK pathways in proliferation and migration of pTr cells, we examined possible cross talk between PI3K-AKT1 and ERK1/2 MAPK cascades. In the present study, we found that MAPK inhibitor (U0126) inhibited effects of VEGF on phosphorylation of ERK1/2 proteins as well as VEGF-induced proliferation and migration of pTr cells, but there was no significant effect on VEGF-induced activation of AKT1. The PI3K inhibitor (LY294002) inhibited VEGF-stimulated phosphorylation of AKT1 proteins as well as VEGF-induced proliferation and migration of pTr cells; however, stimulatory effects of VEGF on phosphorylation of ERK1/2 were also abolished by LY294002. Taken together, these results suggest that the ERK1/2 MAPK cell signaling pathway is regulated by the PI3K pathway, which regulates proliferation and migration of pTr cells in response to VEGF.
In conclusion, we propose that VEGF from endometria and/ or conceptuses regulates proliferation and migration of porcine conceptuses in a paracrine and/or autocrine manner and that the PI3K-AKT1-mTOR and MAPK signaling pathways are involved in VEGF-induced signal transduction during the peri-implantation period. Further, these VEGF-stimulated pathways appear to exhibit cross talk and be involved in mRNA translation and protein synthesis processes in early pTr cells. Results of the present study provide new insights into the mechanisms by which VEGF regulates growth and development of the porcine conceptus during the peri-implantation period of pregnancy.
